RESUMEN
Onchocerciasis is an endemic disease in Ondo state, Nigeria. Community directed distribution of ivermectin is currently on-going in some local government areas of the state. Randomly selected persons (2 331 males and 2 469 females) were interviewed using a modified rapid assessment procedure for Loa loa (RAPLOA) to assess community directed treatment with ivermectin. The retrospective study evaluated the coverage, impacts and adverse reactions to the drug treatment. A questionnaire was administered by house-to-house visit in six local government areas, implementing community directed treatment with ivermectin (CDTI) in this bioclimatic zone. A total of 2,398 respondents were reported to have participated in the treatment. The overall ivermectin coverage of 49.96% was recorded (range 0 - 52% in different communities). Adverse reactions from ivermectin administration were experienced in 38% of individuals. Diverse adverse reactions experienced included predominantly itching (18.50%); oedema, especially of the face and the limbs (8.2%); rashes (3.4%) and body weakness (2.4%). Expulsion of intestinal worms occurred in 0.96% of the respondents. The occurrence of adverse reactions in relation to age categories was statistically significant. Neither fatal nor severe adverse reactions were reported by respondents. Significantly, despite experienced adverse reactions, continued participation, acceptability and compliance to ivermectin treatment was expressed by the various communities. This attitude is in consonance with the African Programme for Onchocerciasis Control (APOC) objectives. Rev. Biol. Trop. 56 (4): 1635-1643. Epub 2008 December 12.
La oncocercosis es endémica en el estado Ondo, Nigeria. Se seleccionaron 4 800 personas al azar para evaluar con encuesta retrospectiva la cobertura, efectos y reacciones al tratamiento farmacológico con ivermectina administrado por la misma comunidad. La cobertura global de ivermectina fue 50 % con reacciones adversas en 38 % de los individuos. Estas fueron comezón picazón (18%), edema, especialmente de la cara y las extremidades (8%), erupciones cutáneas (3%) y debilidad (2%); dependieron de la edad y no hubo reacciones más graves. La expulsión de las lombrices intestinales se produjo en 96% de los encuestados. A pesar de las reacciones adversas, hubo continuidad, aceptación y cumplimiento del tratamiento con ivermectina, en consonancia con los objetivos del Programa Africano para el Control de Oncocercosis (APOC).
Asunto(s)
Adolescente , Adulto , Anciano , Animales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Antiparasitarios/efectos adversos , Enfermedades Endémicas/prevención & control , Ivermectina/efectos adversos , Loiasis/tratamiento farmacológico , Oncocercosis/tratamiento farmacológico , Antiparasitarios/uso terapéutico , Ivermectina/uso terapéutico , Loiasis/epidemiología , Loiasis/prevención & control , Programas Nacionales de Salud , Nigeria/epidemiología , Oncocercosis/epidemiología , Oncocercosis/prevención & control , Estudios RetrospectivosRESUMEN
A total of 360 randomly selected specimens of Clarias gariepinus (Clariidae) recovered from Lekki Lagoon were examined for intestinal helminth parasites. Parasite prevalence and worm burden were low; 17 (4.72%) of the specimens examined were infected with gastrointestinal helminths. The helminth worms recovered include, three cestodes Polyonchobothrium clarias, S tocksia pujehuni and Wenyonia acuminata and a nematode, Paracamallanus cyathopharynx. There was no statistically significant difference in the infection of the male and female Clarias gariepinus; the infection rates in male and female samples were 5.75% and 3.76% respectively. Parasite prevalence was related to the length and weight of the specimens. The fish samples were observed to show negative allometric growth and smaller samples recorded higher helminth infection.